|Articles|October 15, 2020
Initial Development of SARS-CoV-2 Antigen Assay Using BAMS Technology and MALDI-TOF
Author(s)Bruker Corporation
This work is focused on the development of a novel SARS-CoV-2 spike glycoprotein assay based on BAMS™ assay platform with detection by MALDI-TOF MS.
Related Content
Sponsored Content
Trending on LCGC International
1
Advanced Gas Chromatography Methods for Detecting PFAS Contamination in Soil
2
More Tools for Sample Injection When Faced with Mobile Phase/Sample Solvent Mismatch
3
GC–MS Maps Sugar Compounds in Sweet Corn
4
LC–MS/MS Detects MCI/MI in Danish Soaps and Shampoos
5